Cetuximab acneiform eruption, a marker of efficacy for metastatic colorectal cancer and head-neck cancer?

被引：0
|
作者：
Dahan, M. Soussan [1 ]
Lapeyre-Mestre, M. [1 ]
Delord, J. P. [2 ]
Montastruc, J. L. [1 ]
Despas, F. [1 ]
机构：
[1] Serv Pharmacol Med & Clin, Toulouse, France
[2] Inst Claudius Regaud, Toulouse, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2014年 / 28卷
关键词：
cetuximab; acneiform eruption; overall survival; metastatic colo-rectal cancer; head-neck cancer;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [31] Cetuximab in metastatic colorectal cancer Reply
    Folprecht, Gunnar
    Koehne, Claus-Henning
    LANCET ONCOLOGY, 2010, 11 (04): : 314 - 314
  • [32] An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
    Giulia Fornasier
    Sara Francescon
    Paolo Baldo
    Advances in Therapy, 2018, 35 : 1497 - 1509
  • [33] EFFICACY OF CETUXIMAB/PANITUMUMAB AFTER PREVIOUS BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
    Gherman, Alexandra
    Cainap, Calin
    Vesa, Stefan-Cristian
    Havasi, Andrei Dan
    Trifon, Alexandra
    Cainap, Simona Sorana
    Crisan, Ovidiu
    Irimie, Alexandru
    FARMACIA, 2020, 68 (04) : 656 - 664
  • [34] Safety and efficacy of short cetuximab infusion for patients with metastatic colorectal cancer
    Alshammari, K.
    Alanazi, R.
    Ali, M. Mohamed
    Abushara, A.
    Al-Abdulaali, A.
    Alotaibi, F.
    Shehata, H.
    Alkaiyat, M.
    Al Qahtani, J.
    Alolayan, A.
    Algarni, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S141 - S141
  • [35] An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
    Fornasier, Giulia
    Francescon, Sara
    Baldo, Paolo
    ADVANCES IN THERAPY, 2018, 35 (10) : 1497 - 1509
  • [36] Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer
    Tanaka, Nobukazu
    Enokida, Tomohiro
    Fujisawa, Takao
    Okano, Susumu
    Wada, Akihisa
    Sato, Masanobu
    Tanaka, Hideki
    Takeshita, Naohiro
    Tahara, Makoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (11) : 1669 - 1674
  • [37] Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer
    Nobukazu Tanaka
    Tomohiro Enokida
    Takao Fujisawa
    Susumu Okano
    Akihisa Wada
    Masanobu Sato
    Hideki Tanaka
    Naohiro Takeshita
    Makoto Tahara
    International Journal of Clinical Oncology, 2022, 27 : 1669 - 1674
  • [38] Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer
    Tanaka, Nobukazu
    Enokida, Tomohiro
    Fujisawa, Takao
    Satou, Masanobu
    Wada, Akihisa
    Tanaka, Hideki
    Takeshita, Naohiro
    Okano, Susumu
    Tahara, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S532 - S532
  • [39] Acneiform rash secondary to cetuximab plus head and neck radiotherapy
    Mydin, Aminudin Rahman
    Armstrong, John G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (01) : 171 - 171
  • [40] Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
    Jimenez, Begona
    Trigo, Jose M.
    Pajares, Bella I.
    Saez, Maria I.
    Quero, Cristina
    Navarro, Victor
    Llacer, Casilda
    Medina, Laura
    Rueda, Antonio
    Alba, Emilio
    ORAL ONCOLOGY, 2013, 49 (02) : 182 - 185
12345